US phase 3 ASTRA (NCT07368959) will enroll across ~12 sites, randomizing patients to a single intracameral administration of ...
WASHINGTON — Patients who received the Tecnis PureSee extended depth of focus IOL had a high tolerance to residual refractive error, according to a study. SAN DIEGO — Semaglutide use was not tied to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results